sar425899 sanofi dual agonist glp-1 glucagon

sar425899 sanofi dual agonist glp-1 glucagon Glucagon‐Like Peptide‐1 (GLP‐1)‐Based Therapeutics: Current Status and Future Opportunities beyond Type 2 Diabetes - Cheang - 2018 - ChemMedChem (ethylsulfinyl) Emerging incretin- and multi-agonist-based treatments

Name: sar425899 sanofi dual agonist glp-1 glucagon Glucagon‐Like Peptide‐1 (GLP‐1)‐Based Therapeutics: Current Status and Future Opportunities beyond Type 2 Diabetes - Cheang - 2018 - ChemMedChem (ethylsulfinyl) Emerging incretin- and multi-agonist-based treatments
Brand: gerloff.com
SKU: 34912781
Price: 26.17 USD
Availability: InStock
Rating: 4.0747 (18 reviews)

SKU: 34912781

4.1

EUR26.17 EUR48.17

Pay in 4 interest-free payments of $6.54 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 10 - Aug 15

Description

Am J Clin Nutr, 2009

Information about case ascertainment was not provided for eight studies [48, 49, 54, 59, 74, 78, 81, 84]

This trial targets adults with obesity or overweight conditions accompanied by weight-related comorbidities and has achieved First Patient First Visit (FPFV)